Cardiovascular & Hematological Disorders - Drug Targets
Title Abbreviation
Cardiovasc Hematol Disord Drug Targets
Electronic ISSN
2212-4063
Readership
Cardiologists, Cardiovascular Surgeons, Hematologists, Pharmacologists, Scientists, Vascular Medicine Specialists
Scope
Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Bentham Science Publishers Ltd.
To see more details about Cardiovascular & Hematological Disorders - Drug Targets,
Subscribe Now!
Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines